Harnessing invariant NKT cells in vaccination strategies

Cerundolo V, Silk JD, Masri SH, Salio M.
Nat Rev Immunol. 2009 Jan;9(1):28-38.

To optimize vaccination strategies, it is important to use protocols that can 'jump-start' immune responses by harnessing cells of the innate immune system to assist the expansion of antigen-specific B and T cells. In this Review, we discuss the evidence indicating that invariant natural killer T (iNKT) cells can positively modulate dendritic cells and B cells, and that their pharmacological activation in the presence of antigenic proteins can enhance antigen-specific B- and T-cell responses. In addition, we describe structural and kinetic analyses that assist in the design of optimal iNKT-cell agonists that could be used in the clinical setting as vaccine adjuvants.

URL: http://www.nature.com/nri/journal/v9/n1/abs/nri2451.html

Pub Med: http://www.ncbi.nlm.nih.gov/pubmed/19079136

created over 14 years ago (4 December 2009)    last modified over 13 years ago (28 September 2011)   [ RDF ]   [ RelFinder ]